Evidence
3 records3 recordsBest grade:Moderate
Biomarkers
LDL Cholesterol
The evidence suggests that Beta-Sitosterol can effectively reduce symptoms of benign prostatic hyperplasia and lower LDL cholesterol levels, with moderate strength in randomized controlled trials and systematic reviews. However, more extensive studies could further clarify its long-term effects and optimal dosing.
BPH symptom reliefMen with benign prostatic hyperplasia · RCTModerate
BPH symptom relief
Men with benign prostatic hyperplasia · RCT
Beta-Sitosterol significantly improved urinary symptoms and flow measures in men with BPH.
Dose: 320 mgDuration: 6 monthsForm: Phytosterol-enriched oil
LDL cholesterol reductionAdults with hyperlipidemia · Systematic reviewModerate
LDL cholesterol reduction
Adults with hyperlipidemia · Systematic review
Beta-Sitosterol modestly lowers LDL cholesterol levels.
Dose: 320 mg
Prostate inflammation reductionMen with prostate inflammation · RCTModerate
Prostate inflammation reduction
Men with prostate inflammation · RCT
Beta-Sitosterol reduced markers of prostate inflammation.
Dose: 320 mgDuration: 6 monthsForm: Phytosterol-enriched oil
Stacks containing Beta-Sitosterol
Explore all →No public stacks include this supplement yet.
Community Insights
Forms & usage▾
How to take it
Take 60–130 mg daily, preferably with meals.
Capsule
Commonly used for prostate health and cholesterol management.
Tablet
Alternative oral form for ease of use.
Softgel
Often combined with other supplements like saw palmetto.
My notes▾
Sign in to keep a private note on Beta-Sitosterol.